KARLA HANSEN: Open Payments
NPI 1578274080 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,784 in 101 payments from 12 companies in 2025. Trend: 2023 $613 · 2024 $1,095 · 2025 $1,784
Food & beverage: $1,700Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 39 | $714 |
| UCB, Inc. | 22 | $283 |
| ABBVIE INC. | 16 | $273 |
| Galderma Laboratories, L.P. | 5 | $112 |
| Novartis Pharmaceuticals Corporation | 5 | $100 |
| Amgen Inc. | 3 | $80 |
| Lilly USA, LLC | 4 | $79 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $39 |
| PFIZER INC. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
Products named: TREMFYA, Bimzelx, SKYRIZI, RINVOQ, NEMLUVIO, COSENTYX, OTEZLA, EBGLYSS.
Industry payments across ID — which companies pay providers there.
